Article

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Department of Biological Sciences, Columbia University, 550 West 120th Street, Northwest Corner Building, MC 4846, New York, NY 10027, USA.
Cell (Impact Factor: 33.12). 05/2012; 149(5):1060-72. DOI: 10.1016/j.cell.2012.03.042
Source: PubMed

ABSTRACT Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathological states. The oncogenic RAS-selective lethal small molecule erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis. Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphologically, biochemically, and genetically distinct from apoptosis, necrosis, and autophagy. We identify the small molecule ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes. Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system x(c)(-)), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death. Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.

Download full-text

Full-text

Available from: Darpan Patel, Mar 30, 2014
1 Follower
 · 
597 Views
  • Source
    • "An interesting hypothesis is that this activation might arise from direct phosphorylation of Caspase 3 or Caspase 6 by MST3 in mice and humans, respectively. Cystine glutamate transporter/Slc7a11, a transporter associated with glutamate toxicity in neurons, a putative substrate of MST3, is active in both neurons and glia (Bridges et al., 2012; Dixon et al., 2012; Jackman et al., 2012). Finally, the identification of eukaryotic elongation factor 1a as a putative MST3 target has implications in translational regulation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mammalian Sterile 20 (Ste20)-like kinase 3 (MST3) is a ubiquitously expressed kinase capable of enhancing axon outgrowth. Whether and how MST3 kinase signaling might regulate development of dendritic filopodia and spine synapses is unknown. Through shRNA-mediated depletion of MST3 and kinase-dead MST3 expression in developing hippocampal cultures, we found that MST3 is necessary for proper filopodia, dendritic spine, and excitatory synapse development. Knockdown of MST3 in layer 2/3 pyramidal neurons via in utero electroporation also reduced spine density in vivo. Using chemical genetics, we discovered thirteen candidate MST3 substrates and identified the phosphorylation sites. Among the identified MST3 substrates, TAO kinases regulate dendritic filopodia and spine development, similar to MST3. Furthermore, using stable isotope labeling by amino acids in culture (SILAC), we show that phosphorylated TAO1/2 associates with Myosin Va and is necessary for its dendritic localization, thus revealing a mechanism for excitatory synapse development in the mammalian CNS. Copyright © 2014 Elsevier Inc. All rights reserved.
    Neuron 12/2014; 84(5):968-82. DOI:10.1016/j.neuron.2014.10.025 · 15.98 Impact Factor
  • Source
    • "Role of iron in AD pathogenesis is substantiated by the effectiveness of metal homeostatic therapies aiming at reducing iron deregulation (Crouch et al., 2007), which results in (1) decreased free iron accumulation and ferroptosis (Dixon et al., 2012); (2) decreased iron-dependent ROS production; and (3) blockade of neurotoxic Aβ-iron conjugates formation (Liu et al., 2012). To date, in vivo evidence for iron chelation by resveratrol is missing, however the compound prevents iron-driven mitochondrial dysfunction by inhibiting glycogen synthase kinase-3 beta activity (a mechanism useful also to prevent tau hyperphosphorylation) (Shin et al., 2009), and by reducing peroxidation of lipoproteins and lipids through its activity as scavenger (Belguendouz et al., 1997; Tadolini et al., 2000). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cognitive impairment is the final outcome of a complex network of molecular mechanisms ultimately leading to dementia. Despite major efforts aimed at unraveling the molecular determinants of dementia of Alzheimer type (DAT), effective disease-modifying approaches are still missing. An interesting and still largely unexplored avenue is offered by nutraceutical intervention. For instance, robust epidemiological data have suggested that moderate intake of red wine may protect against several age-related pathological conditions (i.e., cardiovascular diseases, diabetes, and cancer) as well as DAT-related cognitive decline. Wine is highly enriched in many polyphenols, including resveratrol. Resveratrol is a well recognized antioxidant which may modulate metal ion deregulation outcomes as well as main features of the Alzheimer's disease (AD) brain. The review will discuss the potentiality of resveratrol as a neuroprotectant in dementia in relation to the oxidative stress produced by amyloid and metal dysmetabolism.
    Frontiers in Aging Neuroscience 05/2014; 6:95. DOI:10.3389/fnagi.2014.00095 · 2.84 Impact Factor
  • Source
    • "When the four BJ-derived cells were treated with BSO, an oncogenic HRASselective lethal phenotype was observed under conditions of low cell density (Figure 1E), suggesting that GSH depletion is sufficient for induction of ferroptosis in BJ cells with oncogenic HRAS overexpression, although additional factors may enhance the potency and efficacy of the lethality caused by GSH depletion under more general circumstances. These results indicated that erastin depletes GSH through preventing cystine uptake via inhibition of system x c À (Dixon et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ferroptosis is a form of nonapoptotic cell death for which key regulators remain unknown. We sought a common mediator for the lethality of 12 ferroptosis-inducing small molecules. We used targeted metabolomic profiling to discover that depletion of glutathione causes inactivation of glutathione peroxidases (GPXs) in response to one class of compounds and a chemoproteomics strategy to discover that GPX4 is directly inhibited by a second class of compounds. GPX4 overexpression and knockdown modulated the lethality of 12 ferroptosis inducers, but not of 11 compounds with other lethal mechanisms. In addition, two representative ferroptosis inducers prevented tumor growth in xenograft mouse tumor models. Sensitivity profiling in 177 cancer cell lines revealed that diffuse large B cell lymphomas and renal cell carcinomas are particularly susceptible to GPX4-regulated ferroptosis. Thus, GPX4 is an essential regulator of ferroptotic cancer cell death.
    Cell 01/2014; 156(1-2):317-31. DOI:10.1016/j.cell.2013.12.010 · 33.12 Impact Factor
Show more